SEC Form 4 · accession 0000842023-15-000005
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Norman David Eansor
Officer — SVP Biotech
Period of report
Jul 2, 2015
Accepted (ET)
Jul 6, 2015 · 10:03 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 2, 2015 | M | 1,667 | $0.00 | A | 1,667 | D | |
| Common Stock | Jul 2, 2015 | F | 531 | $96.54 | D | 1,136 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | $0.00 | Jul 2, 2015 | M | 1,667 | D | — | — | Common Stock | 1,667 | 3,333 | D |
| Stock Option (right to buy)F3 | $94.35 | holding | — | — | — | — | Aug 12, 2021 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
- F2On July 2, 2014, the reporting person was granted 5,000 restricted stock units, vesting in three equal installments beginning on July 2, 2015.
- F3Vests 3,750 each on 8/12/15, 8/12/16, 8/12/17 and 8/12/18.